Investors in 'full bull' mode as Covid-19 vaccine hopes run high: BofA survey

LONDON: Investors are in "full bull" mode, deploying more money into emerging

markets

, small-cap stocks and the

banking sector

on hopes a

Covid-19 vaccine

will turn around these hard-hit market segments,

BofA

's monthly investor survey showed on Tuesday.


Global stocks hit a new record high on Monday as positive data for a potential Covid-19

vaccine

came from Moderna, following similarly upbeat data from rival Pfizer. Investors surveyed by BofA expect a "credible vaccine" by January.

The euphoria sent investors' cash levels down to 4.1% in November, from 4.4% last month, to pre-Covid-19 levels last seen in January, according to the survey of 190

fund managers

with $526 billion in assets under management.

Coronavirus outbreak: Live updates
With global economic growth and profit expectations running at a 20-year high among the investors surveyed, the "reopening rotation" into oversold business sectors is likely to continue in the fourth quarter, BofA said.

But the bank advised clients: "We say 'sell the vaccine' in coming weeks/months as we think we're close to 'full bull'."

Meanwhile, in US Treasuries, 73% of the investors surveyed were expecting steeper yield curves -- rates on longer-term US Treasury securities rising faster than short-term rates. Expectations were far higher than after the 2008 Lehman bankruptcy, 2013 taper tantrum and 2016 elections.

For 2021, investors named "long" emerging market assets, S&P 500 and oil as their favourite trades. Nearly half of the investors surveyed by BofA said they expect emerging markets to outperform in 2021.

Stay informed with the latest Business News on Times of India. Explore the list of Bank Holidays, stay informed about Budget 2025, discover the new Income Tax Slabs, and use the Income Tax Calculator for hassle-free tax planning.

Unlock Investment Potential: Enroll in ET's Stock Valuation Workshop - Batch 3. Secure Your Spot Now!